Skip to main content
Book a demo

Build a sourced report around your research questions.

Define the sections, add your files and assessment criteria, and let Maven research the report.

Book a demo
Your outline
01Executive assessment
02Clinical differentiation
03Evidence limits
04Open questions
05References
02 / Clinical differentiation

Differentiate on the evidence.

TherapyEvidence
DupilumabBOREAS · NOTUS
MepolizumabMATINEE
Key findingQuality-of-life benefits differ across the evidence.
02
Building blocks
Comparisons
Publications
Source quotes

Direct the research section by section.

Give each section its own questions and instructions, then save the outline for future assessments.

Bring the team’s context
Attach supporting files and tag drugs, companies, or research items for Maven to use.
Generate reports in bulk
Apply the saved outline across a set of assets or companies.
Your report instructions

Research clinical differentiation for our portfolio review.

Compare endpoints, retain trial-specific limitations, and cite the primary publications.

Maven intelligenceYour files & criteria
Research, synthesize, and check
W
Competitive briefing

Findings, implications, references

X
Supporting comparison

Structured research for further analysis

Reuse the outline for another asset.

Read the assessment with its evidence attached.

COPD competitive briefingResearch report
02 / Clinical differentiation

Differentiate on the evidence the trials establish.

Both therapies reduced COPD exacerbations versus placebo.1, 2, 3 Dupilumab also improved lung function in BOREAS and NOTUS.1, 2

FindingQuality-of-life benefits are not consistent across the evidence.

BOREAS reported an improvement. NOTUS and MATINEE did not show a significant between-group difference.1, 2, 3

What this means for the assessment

Separate exacerbations, lung function, and quality of life in the comparison. Avoid treating results from separate trials as evidence of head-to-head superiority.

1. BOREAS · NEJM 2023 ↗2. NOTUS · NEJM 2024 ↗3. MATINEE · NEJM 2025 ↗

Extend the report with deeper evidence and recurring research.

Get the supporting evidence

Use Smart Tables for drug comparisons and Document Grids for publication-level findings.

Explore Document Grids

Create custom deliverables

Use the Research Agent for PowerPoint, Word, and Excel files in your team’s templates.

Explore agent deliverables

Bring the questions your next report needs to answer.

Request a trial